LPTX - LEAP THERAPEUTICS, INC.
0.3416
0.007 1.903%
Share volume: 139,062
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.34
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-13-2024 | 03-26-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 14.579 M | 21.252 M | 17.855 M | 16.371 M | |
| Selling general and admin | 3.526 M | 3.367 M | 2.940 M | 3.013 M | |
| Research and development | 11.053 M | 17.885 M | 14.915 M | 13.358 M | |
| Total expenses | 14.579 M | 21.252 M | 17.855 M | 16.371 M | |
| 45.77% | -15.98% | -8.31% | |||
| Operating income | -14.825 M | -21.252 M | -17.855 M | -16.125 M | |
| Ebit | -14.841 M | -20.993 M | -18.362 M | -15.903 M | |
| Pretax income | 0.000 | -20.128 M | -17.468 M | -29.374 M | |
| inf% | -13.22% | 68.16% | |||
| Income tax | 0.000 | 0.000 | 708.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -13.820 M | -20.128 M | -18.176 M | -15.431 M | |
| -45.64% | 9.70% | 15.10% |
